Computed tomography market is estimated to be valued at USD 9.07 Bn in 2025 and is expected to reach USD 14.09 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 6.5% from 2025 to 2032.
Computed tomography (CT) is a diagnostic device that is used as imaging tool for diagnosing diseases, abnormality, and trauma. These scanners provide various images in the form of 3D images, 2D images, and cross-sectional images. Rising usage of CT scanners for wide range of applications such as oncology, neurology and others. Thus, this offers the opportunity to various manufacturers to offer various kinds of CT scanners such as stationary and portable CT scanners.
|
Event |
Description and Impact |
|
Geopolitical Trade Tensions and Tariff Policies |
|
|
Healthcare Regulatory and Reimbursement Shifts |
|
|
Supply Chain Disruptions and Component Shortages |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
The advance developed technologies that are adopted by the health care sector with faster imaging of the organs, tissues, blood vessels and other with increased diagnosis of the disorder with increased imaging may boost the market of computed tomography.
Enhance development and technologies with various techniques available with increased feature may enhance the market of computed tomography and development of infrastructures in the health care sectors.
Increasing number of chronic disorders with increased imaging disorders such as cardiovascular disorder, orthopedics, oncology disorder, brain injury with increased imaging of the disorder with increased diagnosis helps to boost the market of computed tomography.
Increasing disorder among the geriatric population with increase in demands from the customers with developed technologies in computed technology. Advancements in the computed tomography with quick imaging and diagnosis of the organs, tissues, blood vessel with increased scanning and faster results with increased adoption of the computed tomography from past few years. Decreased cost of the computed tomography led to significant rise of the market. Government with increased interest for development of advance technologies in the medical sectors with increased investment for new developments in the market.
The key market players with introduction of new features in computed tomography with integration of software with increased connectivity and increased investment from the players helps to boost the market to grow at a larger extend during the forecast period.
By product type, the stationary CT scanners segment is expected to dominate the global computed tomography market with 56.0% share throughout the forecast period. Stationary systems remain the cornerstone of diagnostic imaging in hospitals due to their advanced imaging capabilities, higher resolution, and integration with hospital IT systems.
While portable CT scanners are gaining traction—especially for bedside use in intensive care units—their adoption actually complements, rather than replaces, stationary systems. As portable scanners handle urgent, on-site diagnostics, physicians can optimize scheduling and utilization of high-performance stationary CT units for in-depth imaging, improving overall workflow efficiency and patient throughput in clinical settings.
In terms of application, oncology is projected to be the leading segment in the computed tomography market during the forecast period. The rising global burden of cancer and the need for early, accurate tumor detection are major drivers of CT scanner adoption in oncology.
CT systems are widely used for both initial diagnosis and treatment monitoring in cancer patients, often serving as a critical tool in radiotherapy planning and disease staging. As more health systems prioritize cancer screening and precision medicine, demand for CT in oncology continues to surge.
Among end-user segments, hospitals are expected to account for the largest share of the global CT market. Hospitals represent the primary point of care for patients requiring advanced imaging, and they typically possess the infrastructure and clinical expertise to operate high-capacity CT systems.
With applications ranging from trauma care to cardiovascular diagnostics and cancer treatment planning, CT scanners are deeply embedded in hospital workflows. Additionally, ongoing investments in hospital infrastructure and the expansion of radiology departments across both developed and emerging economies are supporting sustained demand in this segment.
To learn more about this report, Download Free Sample
North America is projected to maintain a dominant position in the global computed tomography (CT) market through the forecast period, accounting for an estimated 45.30% of the total market share in 2025. This regional dominance is driven by increasing diagnostic applications of CT in clinical settings, particularly for cardiovascular, oncology, and emergency imaging.
Furthermore, the presence of leading healthcare providers, robust reimbursement structures, and increasing demand for non-invasive diagnostic tools are contributing to the strong adoption of advanced CT systems across hospitals and imaging centers in the U.S. and Canada.
Asia Pacific is anticipated to emerge as the fastest-growing region in the global computed tomography market, driven by rapid improvements in healthcare infrastructure, rising healthcare expenditure, and increasing awareness of early disease diagnosis. Countries such as China, India, and South Korea are investing heavily in upgrading their diagnostic imaging capabilities to meet rising patient volumes and improve clinical outcomes.
Public-private partnerships and national health initiatives across the region are supporting broader CT scanner deployment in both urban and rural medical facilities. Additionally, the region’s large aging population and growing burden of chronic diseases are driving demand for high-resolution, low-dose CT imaging technologies.
The U.S. remains the largest market for computed tomography in North America, supported by advanced medical infrastructure, a high volume of diagnostic procedures, and rapid adoption of next-generation imaging systems. Continued investment in research and development, along with favorable reimbursement and regulatory pathways, is enabling manufacturers to introduce cutting-edge CT technologies for a wide range of clinical applications.
China plays a pivotal role in the Asia Pacific CT market, benefiting from a vast healthcare network and strategic government focus on digital health transformation. Local companies are increasingly innovating CT systems that balance affordability and functionality, helping improve access to diagnostic imaging across tier-2 and tier-3 cities. Ongoing healthcare reforms and the rise of public-private partnerships are further driving the expansion of CT deployment in the country.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 9.07 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 6.5% | 2032 Value Projection: | USD 14.09 Bn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
GE Healthcare, Koninklijke Philips N.V., NeuroLogica Corporation, Neusoft Medical Systems Co. Ltd., Hologic, Carestream Health, Toshiba, Analogic, Arineta Ltd., Eaton, Siemens Healthineers AG, FUJIFIM Corporation, Kromek, Shanghai United Imaging Healthcare Co., Ltd., Lumafield, Xoran Technologies and Koning Corporation |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Increasing adoption of inorganic growth strategies such as technological advancement is expected to drive the market growth over the forecast period. For instance, on April 19, 2023, Kromek, a medical technology company, and Analogic Corporation, a healthcare company, collaborated to develop zinc telluride (CZT) based detector system for photon computed tomography applications in medical imaging and security systems.
Increasing approvals from the regulatory authorities such as U.S. Food and Drug Administration (U.S. FDA) is expected to drive the global computed tomography market growth over the forecast period.
Increasing adoption of inorganic growth strategies such as investments is expected to drive the growth of the global computed tomography market over the forecast period.
*Definition: Computed tomography (CT) is a diagnostic device that is used as imaging tool that helps in diagnosing diseases, abnormality, and trauma. These scanners create various images in the form of 3D images, 2D images, and cross-sectional images, which study the internal injuries, complicated tissues or abnormalities, which help in taking early prevention measures to avoid further health risk. The major advantage of computed tomography is the ability to scan bone, blood vessels, and soft tissue at the same time.
Share
Share
About Author
Manisha Vibhute is a consultant with over 5 years of experience in market research and consulting. With a strong understanding of market dynamics, Manisha assists clients in developing effective market access strategies. She helps medical device companies navigate pricing, reimbursement, and regulatory pathways to ensure successful product launches.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
Schedule a meeting with report Author
